MedPath

Duodenal Switch With a Standard Versus Long Alimentary Limb

Not Applicable
Completed
Conditions
Bariatric Surgery Candidate
Obesity, Morbid
Metabolism Disorder
Interventions
Procedure: Long alimentary limb BPD-DS
Registration Number
NCT03097926
Lead Sponsor
Laval University
Brief Summary

The aim of this study was to determine if Biliopancreatic Diversion with Duodenal Switch (BPD-DS) with a longer strict alimentary limb at the expense of a shorter biliopancreatic limb will offer significant weight lost, but with lesser gastrointestinal complaints, protein deficiency, vitamin and trace element deficit compared to standard BPD-DS.

Detailed Description

This two-group, randomized, single-blind pilot study is conducted in a university-affiliated tertiary care center. The study protocol was approved by our ethic committee. Enrollment and randomization of the patients occurred between May 20163 and June 2015. Patients are undergoing follow-up evaluation. Patients were initially referred to our center for a bariatric surgery evaluation. Eligible patients were 18 years of age or older and met the criteria for a laparoscopic biliopancreatic diversion. Patients were excluded if they had a BMI ≥ 50 mg/m², a pacemaker, cirrhosis or if they were planing pregnancy in the next 2 years. Each patient was required to provide written informed consent. Patients were randomly assigned in a 1:1 ratio to undergo a standard biliopancreatic diversion (control group) or a modified biliopancreatic diversion with a longer strict alimentary limb (study group). A sealed envelope with the assignation was given to the surgeon in the operation room just before the procedure. Patients are followed every 6 months after surgery, up to 24-months for clinical evaluation, resolution of comorbidities, evaluation of side-effects, quality of life, bioimpedance testing and bloodwork.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Candidates for a biliopancreatic diversion, BMI above 35 with comorbidities or above 40 without comorbidities
Exclusion Criteria
  • BMI ≥ 50 mg/m², pacemaker, cirrhosis or planning pregnancy in the next 2 years, hypoalbuminemia, irritable bowel syndrome.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard BPD-DSLong alimentary limb BPD-DSStandard BPD-DS with a 250-cm alimentary limb and 100-cm common channel
Long alimentary limb BPD-DSLong alimentary limb BPD-DSBPD-DS with a 100-cm common channel, a 100-cm biliary limb, the remaining bowel as the strict alimentary channel
Primary Outcome Measures
NameTimeMethod
Total weight change6, 12, 18, 24 months

Changes in total body weight, in kg, from baseline

Secondary Outcome Measures
NameTimeMethod
Changes in Quality of life6, 12, 18, 24 months

Measure of Quality of life using Short-Form 36

Changes in Gastro-intestinal side-effects scores6,12,18,24 months

Gastro-intestinal symptoms assessed by measuring changes in GI Score

© Copyright 2025. All Rights Reserved by MedPath